@article{7cccff9c3a3c4efe8a8c3a8e17f7ef27,
title = "Caloric and macronutrient intake differ with circadian phase and between lean and overweight young adults",
abstract = " The timing of caloric intake is a risk factor for excess weight and disease. Growing evidence suggests, however, that the impact of caloric consumption on metabolic health depends on its circadian phase, not clock hour. The objective of the current study was to identify how individuals consume calories and macronutrients relative to circadian phase in real-world settings. Young adults (n = 106; aged 19 ± 1 years; 45 females) photographically recorded the timing and content of all calories for seven consecutive days using a smartphone application during a 30-day study. Circadian phase was determined from in-laboratory assessment of dim-light melatonin onset (DLMO). Meals were assigned a circadian phase relative to each participant{\textquoteright}s DLMO (0 ◦ , ~23:17 h) and binned into 60 ◦ bins. Lean (n = 68; 15 females) and non-lean (n = 38, 30 females) body composition was determined via bioelectrical impedance. The DLMO time range was ~10 h, allowing separation of clock time and circadian phase. Eating occurred at all circadian phases, with significant circadian rhythmicity (p < 0.0001) and highest caloric intake at ~300 ◦ (~1900 h). The non-lean group ate 8% more of their daily calories at an evening circadian phase (300 ◦ ) than the lean group (p = 0.007). Consumption of carbohydrates and proteins followed circadian patterns (p < 0.0001) and non-lean participants ate 13% more carbohydrates at 240 ◦ (~1500 h) than the lean group (p = 0.004). There were no significant differences when caloric intake was referenced to local clock time or sleep onset time (p > 0.05). Interventions targeting the circadian timing of calories and macronutrients for weight management should be tested.",
keywords = "Body composition, Caloric intake, Melatonin, Metabolism, Sleep duration",
author = "McHill, {Andrew W.} and Czeisler, {Charles A.} and Phillips, {Andrew J.K.} and Leigh Keating and Barger, {Laura K.} and Marta Garaulet and Scheer, {Frank A.J.L.} and Klerman, {Elizabeth B.}",
note = "Funding Information: Funding: This work was supported by NIH (F32DK107146, T32HL007901, KL2TR002370, K24HL105664, R01HL114088, R01GM105018, R01HL128538, P01AG009975, R21HD086392, R00HL119618, R01DK099512, R01DK105072 and R01HL118601) and NSBRI (HFP02802, HFP04201, HDP0006). F.A.J.L.S. was supported in part by NIH grants R01HL118601, R01DK099512, R01DK102696, and R01DK105072 and R01HL140574. M.G. was supported by the Spanish Government of Investigation, Development and Innovation (SAF2017-84135-R) including FEDER co-funding, and NIDDK R01DK105072. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. Funding Information: Conflicts of Interest: A.J.K.P., L.K, K.Y., and M.G. have no competing interests to disclose; A.W.M. reports speaker honorarium or travel reimbursement fees from the Utah Sleep Research Society and the California Precast Concrete Association; C.A.C. has received consulting fees from or served as a paid member of scientific advisory boards for: Columbia River Bar Pilots; Gan{\'e}sco Inc., Institute of Digital Media and Child Development, Klarman Family Foundation, Samsung Electronics, Vanda Pharmaceuticals, Washington State Board of Pilotage Commissioners, and Zurich Insurance Company, Ltd. C.A.C. has also received education/research support from Optum, Philips Respironics, Inc., San Francisco Bar Pilots, Schneider Inc., Sysco, and Vanda Pharmaceuticals. The Sleep and Health Education Program of the Harvard Medical School Division of Sleep Medicine, and the Sleep Matters Initiative (which C.A.C. directs) have received funding for educational activities from Cephalon, Inc., Jazz Pharmaceuticals, ResMed, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sanofi-Aventis, Inc., Sepracor, Inc., Wake Up Narcolepsy, and Mary Ann and Stanley Snider via Combined Jewish Philanthropies. C.A.C. is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker). Since 1985, C.A.C. has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, South Carolina Central Railroad Co., Stric-Lan Companies LLC and United Parcel Service (UPS). C.A.C. owns or owned an equity interest in Vanda Pharmaceuticals. He received royalties from Houghton Mifflin Harcourt/Penguin, McGraw Hill and Koninklijke Philips Electronics, N.V. for the Actiwatch-2 and Actiwatch-Spectrum devices. Dr. Czeisler{\textquoteright}s interests were reviewed and managed by Brigham and Women{\textquoteright}s Hospital and Partners HealthCare in accordance with their conflict of interest policies. L.K.B. is on the scientific advisory board of CurAegis Tehcnologies. F.A.J.L.S. has received lecture fees from Bayer HealthCare, Sentara HealthCare, Philips, Vanda Pharmaceuticals, and Pfizer Pharmaceuticals. E.B.K. has received travel reimbursement from the Sleep Research Society and the National Sleep Foundation, and consulted for Pfizer Pharmaceuticals. Publisher Copyright: {\textcopyright} 2019 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2019",
month = mar,
doi = "10.3390/nu11030587",
language = "English (US)",
volume = "11",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",
}